Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Backers
2
Band of Angels, Sofia Fund
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
May 8, 2025 Took on debt financing $2.3M · SEC Form D 2017 Founded
Funding rounds
RoundDateAmountInvestorsSource
Debt Financing May 2025 $2.3M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Strategikon Pharma, Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Mark Di IanniExecutive Officer, DirectorSEC Form D
Paulo CarvalhoExecutive OfficerSEC Form D
Anca CopaescuExecutive Officer, DirectorSEC Form D
Mark WeinsteinExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs

Overview

Cutting edge solutions to optimize your clinical business operations; budgeting planning, vendor management, for efficiency and cost savings!

People

Mark Di Ianni
Executive Officer, Director
Paulo Carvalho
Executive Officer
Anca Copaescu
Executive Officer, Director
Mark Weinstein
Executive Officer, Director
Rob Hess
Director
Debra Apruzzese
Director
Chris Codeanne
Director
Vincent Lepreux
Director
Nathanael Lentz
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
2
Hiring now
0
Countries
1
Loading the map
Headquarters Builds here Office with open vacancies No open vacancies right now Tap a pin for the office
San Rafael United States
HQ
San Francisco United States
Regional office
1 Sansome Street, 35th Floor PMB #40621, San Francisco, CA, 94104, US
company site

Financials

Total raised
$2.3M
Latest round
Debt Financing
Funding rounds
1
Funding rounds
Round Announced Amount
Debt Financing 2025 $2.3M Details